Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gemma Medcalf

Roche Basel Switzerland

Roche’s Gazyvaro flunks trial in non-Hodgkin’s lymphoma

Failed to improve progression-free survival when compared with its MabThera/Rituxan therapy

- PMLiVE

Recordati snaps up Swiss pharma company Pro Farma

Follows group's recent acquisition of Italian firm Italchimici

- PMLiVE

Santhera facing long delay for muscular dystrophy drug in US

FDA rejects accelerated marketing application for Raxone to await phase II trial results

Onyx Health boosts healthcare practice

Trevor Pill, Alex Gandhi and Ryan Gibson join the agency

- PMLiVE

Onyx Health boosts healthcare practice

Trevor Pill, Alex Gandhi and Ryan Gibson join the agency

- PMLiVE

The Netherlands leads Europe for future health

And benchmarking report finds UAE best placed to meet healthcare challenges

- PMLiVE

US health spending to outstrip GDP growth

New report predicts spending on healthcare will account for 20.1% of the total US economy by 2025

- PMLiVE

Celgene’s Revlimid cleared for aggressive lymphoma type in EU

Analysts anticipate sales of up to $10bn for the newly-expanded drug in coming years

- PMLiVE

Juno cleared to restart CAR-T trial after deaths

Study attributes fatalities to pre-conditioning therapy, not the cancer immunotherapy

- PMLiVE

Dr Andrew Mulberg moves from FDA to Amicus Therapeutics

He becomes vice president of regulatory strategy

Deal Watch June 2016

Allergan, Novartis and Merck & Co are among those featured in this month's round-up of pharma deal activity

- PMLiVE

Blue Latitude Health expands into the US

New York City office will be led by James Atherton

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links